GLG News Analyses of the following article:
WellPoint likely to follow FDA on anemia drugs
Published at: www.reuters.com
-
Joe AtkinsChief Executive OfficerMedical Concepts & Innovations
Anemia Drugs Have Been Abused for Profit!
April 30, 2008
Over the last year, it has become clear that the over-use of anemia drugs for cancer and renal failure has become a problem. The reason can be sumed up in one word, which is profit.
-
Wellpoint restricting epo products. Am I surprised?? No!!
April 22, 2008
A major insurer (Wellpoint) is using the guidelines of the FDA to restrict erythropoietin (Epo) use.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.